| Theranostic impact of NG2/CSPG4 proteoglycan in cancer PA Nicolosi, A Dallatomasina, R Perris Theranostics 5 (5), 530, 2015 | 76 | 2015 |
| Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy S Buti, A Leonetti, A Dallatomasina, M Bersanelli Core evidence, 23-36, 2016 | 65 | 2016 |
| Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality E Tamburini, A Dallatomasina, J Quartararo, B Cortelazzi, D Mangieri, ... The FASEB Journal 33 (3), 3112-3128, 2019 | 35 | 2019 |
| Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets F Girolamo, A Dallatomasina, M Rizzi, M Errede, T Wälchli, MT Mucignat, ... PLoS One 8 (12), e84883, 2013 | 31 | 2013 |
| Physiological levels of chromogranin A prevent doxorubicin‐induced cardiotoxicity without impairing its anticancer activity C Rocca, F Scavello, B Colombo, AM Gasparri, A Dallatomasina, ... The FASEB Journal 33 (6), 7734-7747, 2019 | 23 | 2019 |
| Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms A Corsello, L Di Filippo, S Massironi, F Sileo, A Dolcetta Capuzzo, ... PLoS One 13 (5), e0196858, 2018 | 18 | 2018 |
| Regulation of tumor growth by circulating full-length chromogranin A F Curnis, A Dallatomasina, M Bianco, A Gasparri, A Sacchi, B Colombo, ... Oncotarget 7 (45), 72716, 2016 | 18 | 2016 |
| Spatiotemporal regulation of tumor angiogenesis by circulating chromogranin A cleavage and neuropilin-1 engagement A Dallatomasina, AM Gasparri, B Colombo, A Sacchi, M Bianco, ... Cancer Research 79 (8), 1925-1937, 2019 | 9 | 2019 |
| Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma M Reni, V Andreasi, AM Gasparri, E Dugnani, B Colombo, M Macchini, ... Frontiers in Oncology 10, 613582, 2020 | 3 | 2020 |
| STRUCTURAL AND FUNCTIONAL TRAITS OF NG2/CSPG4 PROTEOGLYCAN IN RELATION TO ITS ROLE IN TUMORS A Dallatomasina Università degli Studi di Parma. Dipartimento di Biochimica e Biologia …, 2013 | 1 | 2013 |
| A new predictive sensor for the doxorubicin-dependent cardiotoxicity: The paradigm of chromogranin-A C Rocca, MC Granieri, B Colombo, AM Gasparri, A Dallatomasina, ... Vascular Pharmacology 132, 106745, 2020 | | 2020 |
| Physiological levels of sympatho-chromaffin Chromogranin A exert potent cardioprotection C Rocca, F Scavello, B Colombo, AM Gasparri, A Dallatomasina, ... ACTA PHYSIOLOGICA 227, 166-166, 2019 | | 2019 |
| Pro-apoptotic anti-NG2/CSPG4 monoclonal antibodies for disease therapy R Perris, A Dallatomasina, E Tamburini, P Nicolosi, M Mucignat | | 2019 |
| Pro-apoptotic anti-ng2/cspg4 antibodies and their uses for disease therapy R Perris, A Dallatomasina, PA Nicolosi, E Tamburini, MT Mucignat US Patent App. 15/538,659, 2017 | | 2017 |
| Diversified Expression of NG2/CSPG4 Isoforms in Glioblastoma and Human Foetal Brain Identifies Pericyte Subsets (vol 8, e84883, 2013) F Girolamo, A Dallatomasina, M Rizzi, M Errede, T Waelchli PLOS ONE 9 (4), 2014 | | 2014 |
